Showing results (721-730 of 1,395) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|January 7, 2022
Cancer Diagnoses Following Abnormal Noninvasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management ModelEryn Dow, Alison Freimund, Kortnye Smith, et al.
JCO Precision Oncology|January 7, 2022
Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non-Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorMizuki Nishino, Junwei Lu, Takuya Hino, et al.
JCO Precision Oncology|January 7, 2022
Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non-Small-Cell Lung CancerMichael J Harvey, Rachel Cunningham, Bethany Sawchyn, et al.
JCO Precision Oncology|January 7, 2022
Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective StudyMonica D Levine, Rachel Pearlman, Heather Hampel, et al.
JCO Precision Oncology|January 7, 2022
Evaluation of TP53 Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic TP53 VariantsAlison N Schwartz, Sophie R Hyman, Samantha M Stokes, et al.
JCO Precision Oncology|January 10, 2022
Systematic Review of Molecular Biomarkers Predictive of Resistance to CDK4/6 Inhibition in Metastatic Breast CancerUzma S Asghar, Ruhi Kanani, Rebecca Roylance, et al.
JCO Precision Oncology|January 20, 2022
International Harmonization of Provisional Diagnostic Criteria for ERBB2-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing PanelSatoshi Fujii, Anthony M Magliocco, Jihun Kim, et al.
JCO Precision Oncology|January 20, 2022
Targeting HER2 Alterations in Non-Small-Cell Lung Cancer: A Comprehensive ReviewJing Zhao, Yang Xia
JCO Precision Oncology|January 20, 2022
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 DiabetesMichela Capello, Johannes F Fahrmann, Mayrim V Rios Perez, et al.
JCO Precision Oncology|January 20, 2022
Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational ProfilesBart Koopman, Anthonie J van der Wekken, Arja Ter Elst, et al.
Pageof 140